Clinical Trial Update: A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2) [Phase 3]

View source ↗

Summary

A Phase 3 SURMOUNT-ADOLESCENTS-2 trial evaluating tirzepatide for obesity and weight-related comorbidities in adolescents is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity, Weight Gain | Phase 3 | Status: RECRUITING